These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27462958)

  • 1. When mTORC2-AKT signaling meets cell polarity.
    Daulat AM; Borg JP
    Cell Cycle; 2016 Nov; 15(22):3003-3004. PubMed ID: 27462958
    [No Abstract]   [Full Text] [Related]  

  • 2. PRICKLE1 Contributes to Cancer Cell Dissemination through Its Interaction with mTORC2.
    Daulat AM; Bertucci F; Audebert S; Sergé A; Finetti P; Josselin E; Castellano R; Birnbaum D; Angers S; Borg JP
    Dev Cell; 2016 May; 37(4):311-325. PubMed ID: 27184734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
    Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
    Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
    Holmes B; Benavides-Serrato A; Freeman RS; Landon KA; Bashir T; Nishimura RN; Gera J
    Oncogene; 2018 Feb; 37(6):732-743. PubMed ID: 29059166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.
    Xu K; Chen G; Li X; Wu X; Chang Z; Xu J; Zhu Y; Yin P; Liang X; Dong L
    Sci Rep; 2017 Feb; 7():41718. PubMed ID: 28176801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of microRNA-424 relieved diabetic nephropathy by targeting Rictor through mTOR Complex2/Protein Kinase B signaling.
    Wang G; Yan Y; Xu N; Hui Y; Yin D
    J Cell Physiol; 2019 Jul; 234(7):11646-11653. PubMed ID: 30637733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing Tumor-Promoting and -Suppressive Functions of Rictor/mTORC2 Signaling in Adult Glioma and Pediatric SHH Medulloblastoma.
    Akgül S; Li Y; Zheng S; Kool M; Treisman DM; Li C; Wang Y; Gröbner S; Ikenoue T; Shen Y; Camelo-Piragua S; Tomasek G; Stark S; Guduguntla V; Gusella JF; Guan KL; Pfister SM; Verhaak RGW; Zhu Y
    Cell Rep; 2018 Jul; 24(2):463-478.e5. PubMed ID: 29996106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome and Phosphoproteome Analysis of Brown Adipocytes Reveals That RICTOR Loss Dampens Global Insulin/AKT Signaling.
    Entwisle SW; Martinez Calejman C; Valente AS; Lawrence RT; Hung CM; Guertin DA; Villén J
    Mol Cell Proteomics; 2020 Jul; 19(7):1104-1119. PubMed ID: 32234964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex.
    Gkountakos A; Pilotto S; Mafficini A; Vicentini C; Simbolo M; Milella M; Tortora G; Scarpa A; Bria E; Corbo V
    Carcinogenesis; 2018 Jul; 39(8):971-980. PubMed ID: 29955840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.
    Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A
    Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis.
    Schmidt KM; Dietrich P; Hackl C; Guenzle J; Bronsert P; Wagner C; Fichtner-Feigl S; Schlitt HJ; Geissler EK; Hellerbrand C; Lang SA
    Neoplasia; 2018 Dec; 20(12):1198-1208. PubMed ID: 30404068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTORC2/RICTOR exerts differential levels of metabolic control in human embryonic, mesenchymal and neural stem cells.
    Chu Q; Liu F; He Y; Jiang X; Cai Y; Wu Z; Yan K; Geng L; Zhang Y; Feng H; Zhou K; Wang S; Zhang W; Liu GH; Ma S; Qu J; Song M
    Protein Cell; 2022 Sep; 13(9):676-682. PubMed ID: 35038130
    [No Abstract]   [Full Text] [Related]  

  • 14. UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer.
    Sane S; Srinivasan R; Potts RA; Eikanger M; Zagirova D; Freeling J; Reihe CA; Antony RM; Gupta BK; Lynch D; Bleeker J; Turaihi H; Pillatzki A; Zhou W; Luo X; Linnebacher M; Agany D; Zohim EG; Humphrey LE; Black AR; Rezvani K
    Oncogene; 2023 May; 42(21):1763-1776. PubMed ID: 37037900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain-activated mTORC2/Akt pathway mediates airway smooth muscle remodelling in asthma.
    Rao SS; Mu Q; Zeng Y; Cai PC; Liu F; Yang J; Xia Y; Zhang Q; Song LJ; Zhou LL; Li FZ; Lin YX; Fang J; Greer PA; Shi HZ; Ma WL; Su Y; Ye H
    Clin Exp Allergy; 2017 Feb; 47(2):176-189. PubMed ID: 27649066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of GCN5L1 in cardiac cells disrupts glucose metabolism and promotes cell death via reduced Akt/mTORC2 signaling.
    Manning JR; Thapa D; Zhang M; Stoner MW; Traba J; Corey C; Shiva S; Sack MN; Scott I
    Biochem J; 2019 Jun; 476(12):1713-1724. PubMed ID: 31138772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Rictor/mTORC2 signaling acts as a pivotal strategy to protect against sensorineural hearing loss.
    Fu X; Li P; Zhang L; Song Y; An Y; Zhang A; Liu W; Ye C; Zhang Y; Yue R; Sun X; Chai R; Wang H; Gao J
    Proc Natl Acad Sci U S A; 2022 Mar; 119(10):e2107357119. PubMed ID: 35238644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
    Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
    J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of mTORC2-induced metabolic reprogramming in monocytes uncouples migration and maturation from production of proinflammatory mediators.
    Jangani M; Vuononvirta J; Yamani L; Ward E; Capasso M; Nadkarni S; Balkwill F; Marelli-Berg F
    J Leukoc Biol; 2022 May; 111(5):967-980. PubMed ID: 34585416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration.
    Razmara M; Monazzam A; Skogseid B
    Cell Commun Signal; 2018 Oct; 16(1):64. PubMed ID: 30285764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.